Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-and-hku-host-the-5th-annual-palliative-care-symposium-for-health-care-workers-in-chinese-population
https://www.med.cuhk.edu.hk/press-releases/cuhk-and-hku-host-the-5th-annual-palliative-care-symposium-for-health-care-workers-in-chinese-population

CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

The 5thAnnual Palliative Care Symposium for Health Care Workers in Chinese Population, jointly organized by the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) and Li Ka Shing Faculty of Medicine at The University of Hong Kong (HKU) with the support of the Li Ka Shing Foundation 'Heart of Gold' Hong Kong Hospice Service Program, was held at the Li Ka Shing Medical Sciences Building in the Prince of Wales Hospital today (10 November). Officiating at the opening ceremony were Prof. T. F. Fok, Dean, Faculty of Medicine, CUHK; Prof. T. M. Chan, Associate Dean (External Relations), Li Ka Shing Faculty of Medicine, HKU; Dr. Chan Yu, Project Manager, Li Ka Shing Foundation; and Dr. Cheung Wai Lun, Director of Cluster Services Division, Hospital Authority. The symposium brings together workers and researchers on palliative care in Chinese societies, as well as international renowned experts to share knowledge and experience in tackling the specific difficulties in carrying out end-of-life care programmes, which will in turn uplift the quality of hospice services to benefit the Chinese population.

 

Professor T. F. Fok, Dean, Faculty of Medicine, the Chinese University of Hong Kong ( 7th right); Dr. Bee Wee, Head of Palliative Care Research and Development; Senior Clinical Lecture in Palliative Care, Sir Micheal Sobell House, University of Oxford, UK (6th right); Professor T. M. Chan, Associate Dean (External Relations), Li Ka Shing Faculty of Medicine, the University of Hong Kong (5th right); Dr. Cheung Wai Lun, Director (Cluster Services), Hospital Authority (4th right); Dr. Katherine Lo (3rd right) and Dr. Chan Yu (1st right) from Li Ka Shing Foundation and the representatives from various cluster hospitals and hospice centres take a group photo in the ceremony

Professor T. F. Fok, Dean, Faculty of Medicine, the Chinese University of Hong Kong ( 7th right); Dr. Bee Wee, Head of Palliative Care Research and Development; Senior Clinical Lecture in Palliative Care, Sir Micheal Sobell House, University of Oxford, UK (6th right); Professor T. M. Chan, Associate Dean (External Relations), Li Ka Shing Faculty of Medicine, the University of Hong Kong (5th right); Dr. Cheung Wai Lun, Director (Cluster Services), Hospital Authority (4th right); Dr. Katherine Lo (3rd right) and Dr. Chan Yu (1st right) from Li Ka Shing Foundation and the representatives from various cluster hospitals and hospice centres take a group photo in the ceremony.

Over 100 health care professionals from different backgrounds took part in the symposium. Dr. Bee Wee, Head of Palliative Care Research and Development and Senior Clinical Lecturer in Palliative Care, Sir Micheal Sobell House, University of Oxford, was invited to deliver a keynote speech titled 'End-of-Life Care for Cancer Patients in Asia' at the Symposium. She is a renowned speaker in the field of palliative care and pain management. Dr. Edward Cheung, Specialist in Palliative Medicine, Department of Medicine, United Christian Hospital; Dr. Lo Sing Hung, Specialist in Palliative Medicine, Department of Clinical Oncology, Tuen Mun Hospital; and Dr. Mansha Khemlani, Specialist in Palliative Medicine, Department of Medicine, Caritas Medical Centre, also shared their experiences in conducting end-of-life care pathway in Hong Kong. Various experts also exchanged their views on holistic care and resources allocation of palliative care among cancer patients.

 

The organizers are indebted to the continued support from the Li Ka Shing Foundation and its sponsorship for this symposium. The Foundation aims at contributing to society by helping those in need to build a better life. Its munificent support in health care has benefited countless patients in Hong Kong, mainland China and worldwide. In 1998, the Foundation pioneered free hospice care services in the mainland with the establishment of the 'Heart of Gold' Hospice Service Programme. The Foundation's total donation of over $450 million has supported 42 hospice centres in the mainland and Hong Kong, serving 20,000 patients annually and benefiting 140,000 cancer patients.

 

The organizers are also thankful to the Hospital Authority which provides patients with comprehensive palliative care services including treatment and support through multidisciplinary collaboration in its palliative care centres.

More Press Releases

The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

Symposium
CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

Research
Insights into B-cells and GPR18 Gene Expression by CU Medicine team  Improve Prediction of Survival in Multiple Cancer Types

Insights into B-cells and GPR18 Gene Expression by CU Medicine team Improve Prediction of Survival in Multiple Cancer Types

Research
CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

Research
CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

Research
CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

Research
CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

Surgical advancement
李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

Donation
Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Awards and honors
CUHK Receives an International Cancer Care Team Award Nominated by Patients

CUHK Receives an International Cancer Care Team Award Nominated by Patients

Awards and honors
CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

Health Campaign
CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

Research
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

Surgical advancement
A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
10th Palliative Care Symposium for Healthcare Workers in Chinese Population: ‘Succession ‧ Innovation’

10th Palliative Care Symposium for Healthcare Workers in Chinese Population: ‘Succession ‧ Innovation’

Symposium
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

Research
CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

Research
CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
The 9th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Integrating Palliative Care into General Care: Paving the Way for the Future’

The 9th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Integrating Palliative Care into General Care: Paving the Way for the Future’

Symposium
The 8th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Advancing Palliative Care in Hong Kong: Opportunities and Challenges’

The 8th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Advancing Palliative Care in Hong Kong: Opportunities and Challenges’

Symposium
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
The 6th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care for Geriatric Cancer Patients’

The 6th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care for Geriatric Cancer Patients’

Symposium
CUHK Advocates Palliative Care for Advanced Dementia Patients with Swallowing Problems

CUHK Advocates Palliative Care for Advanced Dementia Patients with Swallowing Problems

Research
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research
CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

Surgical advancement
Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Surgical advancement
The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

Symposium
Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Clinical service

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.